In its April 2019 NEWSletter, the Patented Medicine Prices Review Board (PMPRB) announced that the Steering Committee on Guidelines Modernization would hold its final meeting on May 13, 2019, to discuss both a draft report of its deliberations and the Working Group’s final report (released March 6, 2019). Once the Steering Committee’s report has been finalized and the regulatory amendments have been published in Part II of the Canada Gazette (expected this spring), the PMPRB will release its draft Guidelines for public consultation.
Related Publications & Articles
-
Update on biosimilars in Canada – March 2023
In this article, we provide a further update on developments regarding biosimilars in Canada.Read More -
CADTH consultation on time-limited reimbursement initiative, and IMC report on what Canada can learn from Europe
The Canadian Agency for Drugs and Technologies in Health has released a consultation document for a Proposed Process for Time-limited Reimbursement Recommendations.Read More -
House of Commons Standing Committee on Health meets for study of the PMPRB
The Standing Committee on Health (HESA) of the House of Commons met on Thursday, April 27, 2023, to begin its study of the Patented Medicine Prices Review Board (PMPRB).Read More